Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TRGFT-201 by Orca Biosystems for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia): Likelihood of Approval
TRGFT-201 is under clinical development by Orca Biosystems and currently in Phase II for Chronic Myelocytic Leukemia (CML, Chronic Myeloid...
TRGFT-201 by Orca Biosystems for Graft Versus Host Disease (GVHD): Likelihood of Approval
TRGFT-201 is under clinical development by Orca Biosystems and currently in Phase I for Graft Versus Host Disease (GVHD). According...
TRGFT-201 by Orca Biosystems for Blood Cancer: Likelihood of Approval
TRGFT-201 is under clinical development by Orca Biosystems and currently in Phase II for Blood Cancer. According to GlobalData, Phase...